Tuesday, August 4, 2015

GlaxoSmithKline CEO Andrew Witty says personnel and facilities unharmed by storm

GlaxoSmithKline CEO Andrew Witty said Wednesday that company personnel and facilities were not harmed when Hurricane-turned-superstorm Sandy hit the East Coast.

GlaxoSmithKline CEO Andrew Witty says personnel and facilities unharmed by storm

0 comments

GlaxoSmithKline chief executive officer Andrew Witty said Wednesday morning that company personnel and facilities were not harmed when Hurricane-turned-superstorm Sandy hit the East Coast of the United States.

"We have not had any injuries, or worse, in terms of personnel and that is the most important thing," Witty said in a conference call with reporters, pegged to the release of third quarter earnings. "We've had business disruptions. But our facilities are fine. We have a new facility going up in Philadelphia, which is also fine."

Glaxo employs about 97,000 people in more than 100 countries, including about 1300 in Center City. Others work in the Pennsylvania towns of Upper Merion, Upper Providence, Conshohocken, Marietta and Pittsburgh, along with New Jersey locations of Clifton and Parsippany.

Workers in Center City, now at Logan Square, are scheduled to begin moving to a new building at the Navy Yard in late December or early in 2013.

Meanwhile, Glaxo reported lower sales revenue of 5 percent and lower profit for the third quarter, which ended Sept. 30.

 

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter